相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
Derek J. Hausenloy et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
Samuel S. Engel et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report
Yoko Noda et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
Yuji Ishibashi et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Effects of sitagliptin beyond glycemic control: focus on quality of life
Yoshiko Sakamoto et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
Junichi Matsubara et al.
CIRCULATION JOURNAL (2013)
Comparison of Glycemic Variability in Patients with Type 2 Diabetes Given Sitagliptin or Voglibose: A Continuous Glucose Monitoring-Based Pilot Study
Chiaki Seo et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Variability and reproducibility of flow-mediated dilatation in a multicentre clinical trial
Marietta Charakida et al.
EUROPEAN HEART JOURNAL (2013)
Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study
Tatsuya Maruhashi et al.
HEART (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes
Andre J. Scheen
POSTGRADUATE MEDICINE (2013)
Dipeptidyl Peptidase-4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow-Mediated Vasodilatation in Type 2 Diabetic Patients
Makoto Ayaori et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Effect of 3-Month Repeated Administration of Miglitol on Vascular Endothelial Function in Patients With Diabetes Mellitus and Coronary Artery Disease
Takuo Emoto et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
Aya Shiraki et al.
ATHEROSCLEROSIS (2012)
Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon-Like Peptide 1-Dependent Mechanism
Limei Liu et al.
HYPERTENSION (2012)
The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
Yoshiaki Kubota et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease
Kei Yunoki et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction
Kei Yunoki et al.
ATHEROSCLEROSIS (2011)
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
P. Anagnostis et al.
DIABETES OBESITY & METABOLISM (2011)
Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
Toru Kato et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Single Administration of α-Glucosidase Inhibitors on Endothelial Function and Incretin Secretion in Diabetic Patients With Coronary Artery Disease - Juntendo University Trial: Effects of Miglitol on Endothelial Vascular Reactivity in Type 2 Diabetic Patients With Coronary Heart Disease (J-MACH)
Makoto Hiki et al.
CIRCULATION JOURNAL (2010)
The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes Possible role of stromal-derived factor-1α
Gian Paolo Fadini et al.
DIABETES CARE (2010)
Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial
Y. Iwamoto et al.
DIABETES OBESITY & METABOLISM (2010)
Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus
Yasuhiko Iwamoto et al.
ENDOCRINE JOURNAL (2010)
Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes
Yun-fei Liao et al.
VASCULAR MEDICINE (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Effects of the Alpha Glucosidase inhibitor Acarbose on Endothelial Function after a Mixed Meal in Newly Diagnosed Type 2 Diabetes
F. Pistrosch et al.
HORMONE AND METABOLIC RESEARCH (2009)
Effect of acarbose on vascular disease in patients with abnormal glucose tolerance
Markolf Hanefeld et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: A randomized crossover study
M Shimabukuro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance
TC Wascher et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
T Nyström et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
M Hanefeld et al.
EUROPEAN HEART JOURNAL (2004)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial
JL Chiasson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
JL Chiasson et al.
LANCET (2002)
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force
MC Corretti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
分享论文
